ASCO 2018 News

Patient Power was on-site at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago to bring you the latest cancer treatment and research news.

The Latest in Non-Hodgkin Lymphoma News From ASCO

Dr. John Leonard from Weill Cornell Medicine joined Patient Power to provide an update on the latest research news in non-Hodgkin lymphoma coming from major medical conferences around the world. Dr. Leonard provides an overview of the news including and explanation of the results of the RELEVANCE study and addresses CAR T-cell therapy.

Published:

A Lung Cancer Roundtable: Takeaways From ASCO 2018

A panel of lung cancer experts weigh in on the latest research and treatment developments announced at ASCO 2018. Watch now to stay up-to-date with current lung cancer news and new generation medicines.

Published:

Updates on CAR T-Cell Therapy in Myeloma: Is the Future Bright?

Where is research today on CAR T-cell therapy for multiple myeloma? Tune in to hear Dr. James Berenson give an expert perspective on the efficacy, value, toxicity and cost of the exciting immunotherapy.

Published:

Can Experts Treat Two Cancers at the Same Time?

If a second cancer arises in the midst of myeloma treatment, do researchers have the tools to treat them simultaneously? Noted myeloma expert Dr. James Berenson discusses the treatment options available and potential risks.

Published:

Are Transplants Still Needed in Myeloma?

With all of the advances in cancer care offered in what many call “the era of precision medicine,” are transplants still recommended for multiple myeloma treatment? Watch now as Dr. James Berenson gives an expert perspective on the current role of transplant in myeloma care.

Published:

Precision Medicine for Prostate Cancer: Treatment News Announced at ASCO 2018

What can genetic testing reveal about your prostate cancer? Is there a link between breast and prostate cancer mutations? Find out now from noted expert Dr. Heather Cheng on location at ASCO 2018.

Published:

ASCO 2018: Updates on the ARROW Study for Myeloma

Can a change in frequency influence the efficacy of a treatment? Dedicated researcher Dr. James Berenson shares results announced at ASCO 2018 from the ARROW study with a once-weekly regimen. How did patients tolerate it? Watch now to find out.

Published:

ASCO 2018: A Patient Advocate's Perspective on Access to Testing, Treatment and Meaningful Data

As technology continues to advance so does the demand for cancer patients to access services like genetic testing to stay informed on their condition. What are the barriers to access? Find out from CML patient advocate Jan Geissler.

Published:

Breast Cancer Research Announced at ASCO 2018: Do All Patients Need Chemotherapy?

Can some breast cancer patients now forego chemo? What new findings are driving researchers toward shorter-term therapies? On location at ASCO 2018, expert Julie Gralow sheds light on the significant advances in breast cancer treatment.

Published:

Showing 9 of 12 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 22, 2018